Russell Investments Group Ltd. acquired a new position in Envision Healthcare Co. (NYSE:EVHC) during the fourth quarter, Holdings Channel reports. The fund acquired 39,301 shares of the company’s stock, valued at approximately $2,527,000.

Other hedge funds also recently bought and sold shares of the company. Seven Bridges Advisors LLC acquired a new stake in Envision Healthcare during the third quarter valued at approximately $119,000. First New York Securities LLC NY acquired a new stake in Envision Healthcare during the third quarter valued at approximately $134,000. Pacer Advisors Inc. boosted its stake in Envision Healthcare by 7.4% in the third quarter. Pacer Advisors Inc. now owns 7,045 shares of the company’s stock valued at $157,000 after buying an additional 484 shares during the period. Laurion Capital Management LP acquired a new stake in Envision Healthcare during the third quarter valued at approximately $223,000. Finally, Howard Hughes Medical Institute boosted its stake in Envision Healthcare by 47.4% in the third quarter. Howard Hughes Medical Institute now owns 11,420 shares of the company’s stock valued at $254,000 after buying an additional 3,672 shares during the period. Hedge funds and other institutional investors own 35.96% of the company’s stock.

Institutional Ownership by Quarter for Envision Healthcare (NYSE:EVHC)

Shares of Envision Healthcare Co. (NYSE:EVHC) opened at 63.16 on Tuesday. The stock’s 50 day moving average price is $68.22 and its 200-day moving average price is $45.67. The stock’s market cap is $7.34 billion. Envision Healthcare Co. has a one year low of $57.32 and a one year high of $83.27.

Envision Healthcare (NYSE:EVHC) last announced its earnings results on Tuesday, February 28th. The company reported $1.15 EPS for the quarter, missing the consensus estimate of $1.24 by $0.09. Envision Healthcare had a net margin of 6.06% and a return on equity of 8.05%. The company had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same period in the prior year, the company earned $1.07 earnings per share. The company’s revenue for the quarter was up 97.4% on a year-over-year basis. On average, equities analysts predict that Envision Healthcare Co. will post $1.40 earnings per share for the current fiscal year.

Your IP Address:

Several analysts have commented on the company. Cantor Fitzgerald restated an “overweight” rating on shares of Envision Healthcare in a report on Thursday, March 16th. TheStreet cut Envision Healthcare from a “b-” rating to a “c+” rating in a report on Thursday, March 9th. Zacks Investment Research cut Envision Healthcare from a “hold” rating to a “sell” rating in a report on Tuesday, March 7th. Royal Bank of Canada restated an “outperform” rating and issued a $80.00 price target (down previously from $87.00) on shares of Envision Healthcare in a report on Wednesday, March 1st. Finally, Jefferies Group LLC restated a “buy” rating and issued a $82.00 price target (down previously from $90.00) on shares of Envision Healthcare in a report on Wednesday, March 1st. One research analyst has rated the stock with a sell rating, three have given a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Envision Healthcare currently has a consensus rating of “Buy” and a consensus price target of $55.80.

In other news, insider Robert Jon Coward sold 1,500 shares of the company’s stock in a transaction on Wednesday, March 1st. The stock was sold at an average price of $65.00, for a total transaction of $97,500.00. Following the completion of the sale, the insider now directly owns 104,319 shares of the company’s stock, valued at $6,780,735. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 2.30% of the company’s stock.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

5 Day Chart for NYSE:EVHC

Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Co. (NYSE:EVHC).

Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.